Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ubie Growth in 2024 Driven by Industry Leading Recognition, Collaborations with Patient Advocacy Groups and an Expanded Reach of More Than 4 Million Users 2024-12-17 22:30
Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program 2024-12-17 22:00
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary 2024-12-17 21:30
Fangzhou Inc. Recognized as an "Outstanding Enterprise in Digital Intelligence" by Analysys Star 2024-12-17 17:26
Great Bay Bio Completes First Close of Series B Financing 2024-12-17 16:42
SK Biopharmaceuticals Inks Research Collaboration Agreement with ProEn Therapeutics Further Accelerating Expansion of Oncology Research and Pipeline for Global Competitiveness in Radiopharmaceuticals 2024-12-17 08:20
Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index 2024-12-17 07:51
Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer 2024-12-17 02:05
Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers 2024-12-16 20:03
Fangzhou Inc. Garners Prestigious "Most Valued Pharmaceutical & Healthcare Enterprise" Award 2024-12-16 18:13
China Pharma Announces the Entry of "At-The-Market" Equity Offering 2024-12-13 21:00
Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101 2024-12-13 12:57
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS 2024-12-13 08:00
2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis 2024-12-13 07:20
New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images 2024-12-12 22:08
CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet Therapy 2024-12-12 21:00
Porton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S. 2024-12-12 21:00
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate 2024-12-12 21:00
KIND Presents Preclinical Results of AND017 in Animal Models of Sickle Cell Disease (SCD), Myelodysplastic Syndromes (MDS), and β-Thalassemia at the 66th American Society of Hematology Meeting and Exposition and Announces FDA Authorization of Investigational New Drug (IND) Application for AND017 for Clinical Trial in Sickle Cell Disease (SCD) 2024-12-12 16:25
RSNA 2024 Spotlight: Careverse Leads the New Trend in Medical AI 2024-12-12 16:04
1 3 4 5 6 7 440